Product Information

APTENSIO XR 10 MG CAPSULE is a brand product labeled by Rhodes Pharmaceuticals L.P., priced at $8.0066 per EA under NDC 42858040145. Its NADAC has been published 87 times since Apr 17, 2024.

APTENSIO XR 10 MG CAPSULE

methylphenidate hydrochloride
$8.0066per EA
DEA Schedule CII

Strength

10 mg/1

NDC

42858040145

Classification

Brand

Dosage Form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Last Updated

12/18/2024

Approval Type

New Drug (NDA)

FDA Application

NDA205831

On Market Since

4/17/2015

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulation

Price Statistics

The NADAC for APTENSIO XR 10 MG CAPSULE has been published 87 times since Apr 17, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$8.0066 per EA
All-time high$8.0100 (May 15, 2024)
All-time low$7.9970 (Nov 20, 2024)
52-week high$8.0066
52-week low$8.0066
Median price$8.0066
Average price$8.0047
Largest weekly change+0.1% (Dec 18, 2024)
Weeks tracked87
Tracking sinceApr 17, 2024

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

N/A

5Y

N/A

All

-0.0%

Generic Alternatives

The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 87% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of APTENSIO XR 10 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for APTENSIO XR 10 MG CAPSULE, manufactured by Rhodes Pharmaceuticals L.P., is $8.0066 per EA (NDC 42858040145), effective Dec 10, 2025.

How has the price of APTENSIO XR 10 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for APTENSIO XR 10 MG CAPSULE has held within roughly two percent of its current level. It has been tracked across 87 weekly CMS publications since Apr 17, 2024.

What are the highest and lowest recorded NADAC prices for APTENSIO XR 10 MG CAPSULE?

Since Apr 17, 2024, the NADAC for APTENSIO XR 10 MG CAPSULE has ranged from a low of $7.9970 (Nov 20, 2024) to a high of $8.0100 (May 15, 2024), with a median of $8.0066 per EA.

Are there cheaper alternatives to APTENSIO XR 10 MG CAPSULE?

Yes. 5 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, METHYLPHENIDATE CD 10 MG CAP, is $1.0525 per EA — about 87% below APTENSIO XR 10 MG CAPSULE.

Who manufactures APTENSIO XR 10 MG CAPSULE?

APTENSIO XR 10 MG CAPSULE (NDC 42858040145) is labeled by Rhodes Pharmaceuticals L.P., and CMS classifies it as a brand product.